Trouble on the pitch: Are professional football players at increased risk of developing amyotrophic lateral sclerosis?

Brain

Volumn 128, Issue 3, 2005, Pages 451-453

  Al Chalabi, Ammar ^a   Leigh, P Nigel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CIGARETTE SMOKING; DRUG USE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FOOTBALL; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INJURY; NOTE; OCCUPATIONAL HAZARD; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; OCCUPATIONAL DISEASE; SPORT;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; OCCUPATIONAL DISEASES; RISK FACTORS; SOCCER;

EID: 15044350355     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh426     Document Type: Note

References (33)

1. Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999; 8: 157-164.
2. Andersen PM, Nilsson P, Keranen ML, Forsgren L, Hagglund J, Karlsborg M, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997; 120: 1723-37.
3. Andersen PM, Sims KB, Xin WW, Kiely R, O'Neill G, Ravits J, et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects, and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 62-73.
4. Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 2003a; 22: 217-28.
5. Armon C. Western Pacific ALS/PDC and flying foxes. What's next? Neurology 2003b; 61: 291-2.
6. Armon C. Excess incidence of ALS in young Gulf war veterans. Neurology 2004; 63: 1986-7.
7. Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes. Implications for ALS-PDC in Guam. Neurology 2003; 61: 387-9.
8. Bruijn LT, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27: 723-49.
9. Cox PA, Sacks OW. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 2002; 58: 956-9.
10. Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 41: 210-21.
11. Haley RW. Excess incidence of ALS in young Gulf war veterans. Neurology 2003; 61: 750-6.
12. Holden C. Peering under the hood of Africa's runners. Science 2004; 305: 637-9.
13. Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf war veterans. Neurology 2003; 61: 742-9.
14. Kurland LT, Mulder D. Epidemiologic investigations of amyotrophic lateral sclerosis. 1. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathological observations. Neurology 1954; 4: 355-78, 438-48.
15. Kurtzke JF. Risk factors in amyotrophic lateral sclerosis. In: Rowland LP, editor. Amyotrophic lateral sclerosis and other motor neuron diseases. Advances in Neurology, Vol. 56. New York: Raven Press; 1991, 245-70.
16. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003; 34: 383-94.
17. Le Galliard JF, Clobert J, Ferriere R. Physical performance and Darwinian fitness in lizards. Nature 2004; 432: 502-5.
18. Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 1998; 55: 201-6.
19. Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2004; 29: 656-62.
20. Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet 2003; 62: 83-101.
21. Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 235-250.
22. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. 1. Cigarette smoking and alcohol consumtion. Am J Epidemiol 2000; 151: 156-163.
23. Nogales-Gadea G, Garcia-Arumi E, Andreu AL, Cervera C, Gamez J. A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance. J Neurol Sci 2004; 219: 1-6.
24. Orrell RW, Habgood JJ, Malaspina A, Mitchell J, Greenwood J, Lane RJ, et al. Clinical characteristics of SOD1 gene mutations in UK families with ALS. J Neurol Sci 1999; 169: 56-60.
25. Plato CC, Garuto RM, Galasko D, Craig U-K, Plato M, Gamst A, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003; 157: 149-57.
26. Rose MR. Gulf war service is an uncertain trigger for ALS. Neurology 2003; 61: 730-1.
27. Ruddy DM, Parton MJ, Al-Chalabi A, Lewis CM, Vance C, Smith BN, et al. Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Hum Genet 2003; 73: 390-6.
28. Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology 2002; 59: 773-5.
29. Shaw CE, Enayat ZE, Chioza BA, Al-Chalabi A, Radunovic A, Powell JF, et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 1998; 43: 390-4.
30. Veldink JH, Bar PR, Joosten EA, Otten M, Wokke JH, ven den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 2003; 13: 737-43.
31. Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, et al. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology 2004; 23: 192-200.
32. Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol 2004; 160: 26-33.
33. Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci 2001; 191: 3-9.